Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +20.21%
#2 Fake World Assets Fake World Assets +8.14%
#3 Tornado Cash Tornado Cash +6.81%
#4 Geodnet Geodnet +6.39%
#5 OriginTrail OriginTrail +6.25%
#6 B3 (Base) B3 (Base) +5.93%
#7 Audiera Audiera +5.37%
#8 Storj Storj +5.26%
#9 Pons Pons +5.16%
#10 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +5.02%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Settings
Language
ENGLISH
Currency
USD
Theme
Neonc Technologies Holdings, Inc. Neonc Technologies Holdings, Inc.

Neonc Technologies Holdings, Inc.

NTHI
Rank in Stocks #20827
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical... NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
Share Price
$4.67
Last synced: 2026-08-21
Market Cap
$121.10M
Change (1 day)
2.41%
Change (1 year)
-19.76%
Country
US
Trade Neonc Technologies Holdings, Inc. (NTHI)

Category

Healthcare
P/B ratio for Neonc Technologies Holdings, Inc. (NTHI)
P/B ratio as of 2026 TTM: 0
According to Neonc Technologies Holdings, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Neonc Technologies Holdings, Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH